The tweet was deleted by the author.
But we saved everything 🙂.
AbbVie announces Q3 2026 earnings call while stock holds steady
AbbVie will host its third-quarter earnings call on October 30 at 8am CT. The stock is little changed on the day, trading near $286.44.
ABBV price prediction
Current price:
$295.03
0.5400
0.18%
Closed
11/13
Daily range
293.56
297.25
297.25
Weekly range
289.62
300.31
300.31
Loading...
Highlights
- AbbVie will announce third-quarter 2026 results on October 30 and is projected to post diluted EPS of $3.76, up 102.2% year over year.
- AbbVie stock is little changed on the day near $286.44, with a market value of about $488.55 billion and trailing revenue of $64.38 billion.
- 97 of 122 analysts rate AbbVie a buy, with the latest RBC Capital rating at outperform and a $280 target.
AbbVie announced it will hold its third-quarter 2026 earnings call and webcast on October 30 at 8am CT. Analysts expect the company to report diluted earnings per share of $3.76 for the quarter, a gain of 102.2% from a year ago, according to Yahoo! Finance. The company has beaten consensus estimates in each of the past four quarters.
View post on X Loading...
Trend remains constructive as shares recover gap and test resistance
The session opened with a gap down from the previous close at $286.74 to $283.88, and price has since recovered part of that move. Shares of AbbVie remain above their MA-20, MA-50, and MA-200, keeping the daily trend constructive. The weekly high at $289.59 acts as the nearest resistance, while RSI at 65.5 shows the stock is nearing overbought territory, suggesting the current advance may be starting to stretch.
Upside odds dominate as traders watch the weekly high for confirmation
Traders should monitor whether price can close above the weekly high at $289.59 for confirmation that buyers are taking control. Earlier in the session, AbbVie stock opened with a gap down from $286.74 to $283.88 before retracing part of the loss. Even so, from here, the probability of further upside stands at more than 80% for the coming trading week, with the downside probability below 20% and an expected trading range between $281.6 and $291.27. A close above the weekly high would show buyers are willing to follow through, while a drop below $278.78 would suggest the move is being faded. On the weekly chart the longer-term picture stays firmly constructive.
Earlier, analysts noted that AbbVie's sustained technical strength alongside regulatory approvals had supported a constructive outlook for the stock. With the company set to report third-quarter results and technical levels holding firm, traders should closely monitor whether shares can decisively break above $289.59 to signal renewed upside momentum.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
